Tag Archives: patent

BMS deal quest gets a boost as Celgene swats aside another Revlimid patent challenge

Much of the investor doubt surrounding Bristol-Myers Squibb’s $ 74 billion Celgene buyout centers on the multiple myeloma blockbuster Revlimid—namely, whether its remaining patents can stand up to legal challenges. But the companies just scored a win in that department. Thursday, the U.S. Patent and Trademark Office’s Patent Trial and Appeal Board (PTAB) decided not… Read More »

Pfizer loses blockbuster drug patent fight in UK Supreme Court

LONDON (Reuters) – Pfizer (PFE.N) lost the final round in a long-running patent battle in Britain on Wednesday after the country’s highest court ruled against it in a case involving its $ 5 billion-a-year pain drug Lyrica. FILE PHOTO: A logo of American pharmaceutical corporation Pfizer Inc., is pictured in Toluca, Mexico October 1, 2018.… Read More »

USITC to investigate Resmed for alleged patent infringement

WASHINGTON (Reuters) – The U.S. International Trade Commission (USITC) said on Friday it would investigate California-based Resmed Inc for a patent infringement complaint related to sleep apnea mask systems. The investigation is based on a complaint by New Zealand medical device maker Fisher & Paykel Healthcare, the commission said in a statement. Fisher & Paykel… Read More »